Biomedical firm Femasys adds former Seventh Generation CMO John Moorhead to its board, leveraging his extensive background in brand scaling and product innovation following a recent private placement.
Femasys announced the appointment of John Moorhead to its Board of Directors in connection with its August 2026 private placement, a routine governance update with limited direct market impact.
Femasys Inc. has appointed John Moorhead to its Board of Directors as part of a governance update linked to the company's August 2026 private placement. Moorhead brings over 20 years of experience in consumer marketing and brand development, including a tenure as Chief Marketing Officer at Unilever’s Seventh Generation.
Moorhead was appointed as a board designee in connection with the company's August 2026 private placement to provide expertise in consumer marketing and brand innovation.